AcelRx Pharmaceuticals, Inc. (ACRX) SEC filings
ACRX SEC filings — 10-K, 10-Q, 8-K and the rest — each read against the price at its own news timestamp. Back to the ACRX overview →
9 measured ACRX SEC filing events.
| Date | Headline | Event | 5-min | To close |
|---|---|---|---|---|
| Form 8-K TALPHERA, INC. For: Jan 17 | SEC filing · Form 8-K | — | — | |
| Form 8-K TALPHERA, INC. For: Jan 12 | SEC filing · Form 8-K | — | — | |
| Form 8-K TALPHERA, INC. For: Jan 09 | SEC filing · Form 8-K | +0.00% | +10.10% | |
| Form EFFECT ACELRX PHARMACEUTICALS | SEC filing · Form EFFECT | -3.90% | -0.78% | |
| Form S-3 ACELRX PHARMACEUTICALS | SEC filing · Form S-3 | +3.05% | +11.27% | |
| Form S-8 ACELRX PHARMACEUTICALS | SEC filing · Form S-8 | +3.05% | +11.27% | |
| Form 10-Q ACELRX PHARMACEUTICALS For: Sep 30 | SEC filing · Form 10-Q | +3.73% | +3.11% | |
| Form 8-K ACELRX PHARMACEUTICALS For: Nov 08 | SEC filing · Form 8-K | -2.76% | -8.60% | |
| Form 8-K ACELRX PHARMACEUTICALS For: Oct 18 | SEC filing · Form 8-K | +7.57% | -3.93% |
Keep exploring
More ACRX: earnings → · analyst actions → · ACRX overview →
Other Healthcare names and their SEC filings
| Ticker | Events | Median 30-min | % positive |
|---|---|---|---|
| PACIFIC HLTH CRE ORGZ INC (PFHO) | 33 | 0.00% | 29% |
| Remedent, Inc. (REMI) | 33 | 0.00% | 0% |
| Aravive, Inc. (ARAV) | 32 | +4.15% | 67% |
| Nemaura Medical, Inc. (NMRD) | 32 | 0.00% | 39% |
Same sector, same measurement: percent move vs. the price at the news timestamp, read at 30 minutes. Sample sizes differ, so the medians are comparable but the confidence behind them is not. These are each name’s all-news baseline, not its SEC filings — that is what the link opens.